JP2018534280A5 - - Google Patents

Download PDF

Info

Publication number
JP2018534280A5
JP2018534280A5 JP2018519006A JP2018519006A JP2018534280A5 JP 2018534280 A5 JP2018534280 A5 JP 2018534280A5 JP 2018519006 A JP2018519006 A JP 2018519006A JP 2018519006 A JP2018519006 A JP 2018519006A JP 2018534280 A5 JP2018534280 A5 JP 2018534280A5
Authority
JP
Japan
Prior art keywords
lyosphere
coating
enteric
formulation
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018519006A
Other languages
English (en)
Japanese (ja)
Other versions
JP6855469B2 (ja
JP2018534280A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/056322 external-priority patent/WO2017066134A1/en
Publication of JP2018534280A publication Critical patent/JP2018534280A/ja
Publication of JP2018534280A5 publication Critical patent/JP2018534280A5/ja
Application granted granted Critical
Publication of JP6855469B2 publication Critical patent/JP6855469B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018519006A 2015-10-16 2016-10-11 消化器標的療法のための処方物を調製するための工程 Active JP6855469B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562242718P 2015-10-16 2015-10-16
US62/242,718 2015-10-16
PCT/US2016/056322 WO2017066134A1 (en) 2015-10-16 2016-10-11 Processes for preparing formulations for gastrointestinal-targeted therapies

Publications (3)

Publication Number Publication Date
JP2018534280A JP2018534280A (ja) 2018-11-22
JP2018534280A5 true JP2018534280A5 (https=) 2019-11-14
JP6855469B2 JP6855469B2 (ja) 2021-04-07

Family

ID=58518514

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018519006A Active JP6855469B2 (ja) 2015-10-16 2016-10-11 消化器標的療法のための処方物を調製するための工程

Country Status (4)

Country Link
US (1) US10617650B2 (https=)
EP (1) EP3362052B1 (https=)
JP (1) JP6855469B2 (https=)
WO (1) WO2017066134A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL319156A (en) * 2017-06-21 2025-04-01 Minerva Neurosciences Inc Controlled-release oral dosage forms are resistant to gastric acid.
EP3503041B1 (en) 2017-12-24 2025-11-12 Dassault Systèmes Design of a 3d finite element mesh of a 3d part that comprises a lattice structure
CN113143887A (zh) * 2018-02-14 2021-07-23 浙江万方生物科技有限公司 一种掩味缓释替米考星预混剂的制备方法
US20210223262A1 (en) * 2018-06-07 2021-07-22 Merck Sharp & Dohme Corp. Lyosphere critical reagent kit
CN108904795B (zh) * 2018-08-29 2022-07-05 温氏食品集团股份有限公司 一种猪流行性腹泻病毒的口服疫苗的制备方法
CN110101678B (zh) * 2019-04-26 2021-04-30 安阳天助药业有限责任公司 改良的含硬脂酸镁的包衣预混剂及制作方法
CN109925294A (zh) * 2019-04-26 2019-06-25 安阳天助药业有限责任公司 一种软胶囊防渗包衣预混剂
EP4078055B1 (en) * 2019-12-16 2025-03-12 Northwestern University Method for forming a circular pellet
WO2022103639A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogs
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
WO2024129555A1 (en) * 2022-12-15 2024-06-20 Merck Sharp & Dohme Llc Lyospheres containing programmed death receptor 1 (pd-1) antibodies and methods of use thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL295570A (https=) * 1962-07-20
US3655838A (en) 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
US3767790A (en) 1972-02-11 1973-10-23 Nat Patent Dev Corp Microorganisms
US3860490A (en) 1972-02-11 1975-01-14 Nat Patent Dev Corp Process of subjecting a microorganism susceptible material to a microorganism
US4397844A (en) 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4377568A (en) 1981-08-12 1983-03-22 Merck Sharp & Dohme (I.A.) Corp. Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same
IL78775A (en) 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
JP3249147B2 (ja) 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
WO1994025005A1 (en) * 1993-04-28 1994-11-10 Akzo Nobel N.V. Lyospheres comprising gonadotropin
NZ295998A (en) * 1994-10-24 1999-10-28 Ophidian Pharm Inc Neutralizing antitoxins against clostridium difficile and clostidium botulinum toxins
US5824339A (en) 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
US6139875A (en) 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
MXPA06002455A (es) * 2003-09-02 2006-08-31 Pfizer Prod Inc Formas de dosificacion de liberacion sostenida de ziprasidona.
US20050233435A1 (en) * 2003-09-04 2005-10-20 Nyu Medical Center Plasmodium axenic liver stages as a noninfectious whole organism malaria vaccine
US7682796B2 (en) * 2003-09-12 2010-03-23 Kozel Thomas R Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases
US20050165038A1 (en) * 2004-01-22 2005-07-28 Maxwell Gordon Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects
US8535640B1 (en) 2005-01-04 2013-09-17 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
EP1954308B1 (en) * 2005-09-16 2011-09-07 Merial Ltd. Stabilizers for freeze-dried vaccines
WO2008085484A2 (en) 2006-12-28 2008-07-17 Jacobus Pharmaceutical Company, Inc. Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid
BR122017025062B8 (pt) 2007-06-18 2021-07-27 Merck Sharp & Dohme anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento
TWI471127B (zh) 2009-04-29 2015-02-01 Intervet Int Bv 供人類使用之口服崩解錠劑的製備方法、所製得之口服崩解錠劑、以及含有該口服崩解錠劑的包裝物
CN102573802A (zh) 2009-08-12 2012-07-11 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
ES2784123T3 (es) 2009-11-04 2020-09-22 Merck Sharp & Dohme Anticuerpo anti TSLP genomodificado
WO2013066769A1 (en) * 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Methods of preparing lyophilized spherical-shaped pellets of biological materials
US20140017318A1 (en) * 2012-07-10 2014-01-16 Kevin O'Connell Method to produce a medicinal product comprising a biologically active protein and the resulting product
US20160228371A1 (en) 2013-10-18 2016-08-11 Abbvie Inc. Stable solid units and methods of making the same

Similar Documents

Publication Publication Date Title
JP2018534280A5 (https=)
ES2588173T3 (es) Uso de un copolímero de (met)acrilato aniónico, parcialmente neutralizado, como revestimiento para la producción de una forma medicamentosa con una liberación del principio activo a valores del pH reducidos
JP6953478B2 (ja) 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
JP5675100B2 (ja) 多層の分離層を有する薬剤形
JP6855469B2 (ja) 消化器標的療法のための処方物を調製するための工程
KR101387835B1 (ko) 코팅된 제약 제형을 제조하기 위한 중합체 혼합물의 용도및 혼합된 중합체성 코팅을 갖는 제약 제형
JP5847303B2 (ja) 医薬品剤形又は機能性食品剤形に適したコーティング組成物
ES2716550T3 (es) Formulación farmacéutica o nutracéutica gastrorresistente que comprende una o más sales de ácido algínico
JP2021119153A (ja) ワクチン組成物
ES2838816T3 (es) Composición farmacéutica o nutracéutica con resistencia contra la influencia de etanol
JP6474421B2 (ja) 持続放出特性を有するとともにエタノールの影響に対する耐性を有する医薬品組成物または栄養機能食品組成物
HRP20230305T1 (hr) Pripravci za ileo-jejunalnu dostavu lijeka
CN104507460A (zh) 抗乙醇影响的抗胃酸药物或保健品组合物
JP2015512441A5 (https=)
WO2018072709A1 (zh) 医药微丸的干粉包衣组合物
JP5160423B2 (ja) 水易溶性薬物含有球状素顆粒の製造方法
JPWO2017022248A1 (ja) 腸溶性カプセル
US20230048354A1 (en) Dosage form for use in treating or preventing of a disease
JP2018521030A5 (https=)
RU2013143149A (ru) Составы, пригодные для вакцин, получаемых сушкой распылением
CN103381268A (zh) 包含质子泵抑制剂的固体药物组合物
US20230012981A1 (en) Dosage form for use in treating or preventing of a disease
Singh et al. Release and cytokine production of BmpB from BmpB-loaded pH-sensitive and mucoadhesive thiolated eudragit microspheres
CN105726488A (zh) 含有呼吸道合胞病毒抑制剂的肠溶微丸及其制备方法
JP2016040307A5 (https=)